ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart/lung transplantation"

  • 2020 American Transplant Congress

    Circulating Exosomes with Cardiac Self-Antigens, Myosin and Vimentin, Induced Immune Responses Leading to Rejection Following Heterotopic Cardiac Transplantation Immunosuppressed with mTOR Inhibitor and Low Dose of IL-2 Therapy

    Y. Itabashi, R. Ravichandran, S. Bansal, T. Fleming, T. Mohanakumar

    Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

    *Purpose: The aim of the study is to determine the role for circulating exosomes with cardiac self-antigens (SAgs) (Myosin, Vimentin) in the development of immune…
  • 2020 American Transplant Congress

    Successful Heart Utilization and Outcomes with Long-Distance Transport of Deceased Donor Hearts: One Large Organ Procurement Organization’s Five-Year Experience

    D. Adorno, C. Wells, K. O'Connor

    LifeCenter Northwest, Bellevue, WA

    *Purpose: Long-distance transport of deceased donor hearts has been associated with reduced organ utilization rates and risk of inferior outcomes. One U.S. Organ Procurement Organization’s…
  • 2020 American Transplant Congress

    Role of Circulating Exosomes in the Induction of Immune Responses Resulting in Cardiac Allograft Rejection in miR155 Knockout Animals

    S. Bansal, Y. Itabashi, M. Smith, R. Bremner, T. Mohanakumar

    Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

    *Purpose: Our goal is to define the mechanism by which circulating exosomes with cardiac self-antigens (SAgs), Myosin, Vimentin, and angiotensin Receptor 1 Protein (AGTR1) leads…
  • 2020 American Transplant Congress

    Evaluation of Oral Candidiasis Incidence at Large Academic Medical Center in Absence of Pharmacologic Prophylaxis at Discharge

    C. Sammons1, M. Norris2, N. Casciello2

    1Hosp of Univ of Pennsylvania, Philadelphia, PA, 2Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA

    *Purpose: Oral candidiasis (OC) is a common complication in solid organ transplant recipients. Despite AST guidelines recommending against universal prophylaxis, it has become common practice…
  • 2020 American Transplant Congress

    Impact of Dialysis and Diabetes on Survival in Recipients of Combined Heart-Kidney Transplant

    J. Parekh1, H. Chau2, G. Schnickel2, J. Berumen2, K. Mekeel2

    1University of California, San Diego, La Jolla, CA, 2Surgery, University of California, San Diego, La Jolla, CA

    *Purpose: Mounting data shows a survival benefit of combined heart-kidney transplantation in patients with heart and renal failure. However, little has been done to understand…
  • 2020 American Transplant Congress

    Cardiac Transplantation is Accompanied by Major T and NK Cell Alterations within the First 24 Hours

    J. Iske1, B. Wiegmann2, K. Ludwig1, N. Ledwoch1, E. Chichelnitskiy1, J. F. Kühne1, A. Hitz1, R. Bellmàs-Sanz1, K. Daemen1, J. Keil1, F. Ius2, S. Rochas2, A. Knoefel2, A. Haverich2, G. Warnecke2, C. S. Falk1

    1Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany, 2Division of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany

    *Purpose: Allogeneic heart transplantation (HTx) displays the only curative approach for terminal heart insufficiency while acute allograft rejection remains a major complication. However, early kinetics…
  • 2020 American Transplant Congress

    Is Ischemia Reperfusion Injury Immediately after Heart Transplantation Correlated to Increased Intimal Thickening in the First Year?

    J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, A. Velleca, L. Czer, F. Esmailian, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Ischemia reperfusion injury (IRI) is not uncommon in heart transplant patients due to high dose inotropes, ischemic time, and technical surgical reasons. Ischemia in…
  • 2019 American Transplant Congress

    What Are You Smoking? The Impact of Donor Drug Use on Long Term Survival Post-Transplant

    D. A. Baran1, A. Long1, J. T. Lansinger2, H. Copeland3, J. M. Herre1, W. Old1, G. Zeevi1, C. Barreiro1, C. Kemp1, B. H. Smith1, K. Stelling1, A. Ingemi1, P. Bourassa1, J. Philpott1

    1Sentara Heart Hospital, Norfolk, VA, 2Eastern Virginia Medical School, Norfolk, VA, 3Division of Cardiothoracic Surgery, University of Mississippi Medical Center, Jackson, MS

    *Purpose: Drug use is a common aspect in the history of heart transplant donors. Whether prior or current drug use is associated with inferior post…
  • 2019 American Transplant Congress

    Slowed Progression of Maximal Intimal Thickening by Intravascular Ultrasound after Initiation of Sirolimus

    A. Putschoegl1, K. Campbell1, M. Everitt1, S. Miyamoto1, B. Pietra2, S. Auerbach1

    1Children's Hospital Colorado, Aurora, CO, 2University of Florida Health, Gainesville, FL

    *Purpose: Evidence in adult heart transplant (HT) patients (pt) shows that initiating sirolimus (SRL) slows progression of cardiac allograft vasculopathy (CAV) measured by intravascular ultrasound…
  • 2019 American Transplant Congress

    A Novel Protocol to Produce Massive Amounts of Autologous Thymus-Derived Treg Cells (ThyTreg) to Be Employed as Cellular Therapy in Heart Transplanted Children: A New Paradigm for the Prevention of Graft Rejection

    E. Bernaldo de Quirós1, R. López1, V. Pérez1, M. Clemente2, J. Gil-Jaurena3, M. Camino4, N. Gil4, E. Panadero4, C. Medrano4, M. Pion1, R. Correa-Rocha1

    1Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain, 2Cell Culture Unit, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain, 3Pediatric Cardiac Surgery Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 4Pediatric Cardiology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    *Purpose: Immune allograft rejection remains the main obstacle to successful transplants. Although transfer of regulatory T cells (Treg) has acquired growing interest in achieving indefinite…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences